Effect of Proprietary Botanical Blend on Glycemic Control and Post-prandial Carbohydrate Absorption
NCT ID: NCT03897517
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-08-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults
NCT03921333
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
NCT02856516
Comparison of Different Types of Resistant Starch
NCT00930956
Effect of a Plant-based Hydrolysates Daily Consumption on the HbA1c of Pre-diabetic Subjects
NCT03851666
Role of Slowly Digesible Starch on Diabetes Risk Factors
NCT01708694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Proprietary Botanical Blend
Proprietary Botanical Blend - Dietary supplement with alpha amylase and sucrase inhibitory activity. 2 capsules
Proprietary Botanical Blend
Oral administration of capsules containing proprietary botanical blend 30 minutes prior to carbohydrate ingestion.
Placebo
Non/minimally nutritive nonactive material: rice flour. 2 capsules
Placebo
Oral administration of capsules containing rice flour (placebo) 30 minutes prior to carbohydrate ingestion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Proprietary Botanical Blend
Oral administration of capsules containing proprietary botanical blend 30 minutes prior to carbohydrate ingestion.
Placebo
Oral administration of capsules containing rice flour (placebo) 30 minutes prior to carbohydrate ingestion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women
* Able to provide written consent in English
* A body mass index between 23.0 and 30.0 kg/m2
* A fasting serum blood glucose level between 100.0 and 126.0 mg/dL
Exclusion Criteria
* Having a BMI less than 23.0 kg/m2 and higher than 30.0 kg/m2
* Having a fasting blood glucose level less than 100.0 mg/dL and higher than 126.0 mg/dL
* Suffering from known serious cardiac, hepatic, renal, pulmonary, gastrointestinal, endocrine or hematological disease based on investigator determination, aside from pre-diabetes
* Currently pregnant or breastfeeding
* Consuming more than 2 alcoholic drinks per day on average.
* Weight loss of more than 5% of body weight over the past 6 months
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Plexus Worldwide
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Augustin LSA, Kendall CWC, Jenkins DJA, Willett WC, Astrup A, Barclay AW, Bjorck I, Brand-Miller JC, Brighenti F, Buyken AE, Ceriello A, La Vecchia C, Livesey G, Liu S, Riccardi G, Rizkalla SW, Sievenpiper JL, Trichopoulou A, Wolever TMS, Baer-Sinnott S, Poli A. Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutr Metab Cardiovasc Dis. 2015 Sep;25(9):795-815. doi: 10.1016/j.numecd.2015.05.005. Epub 2015 May 16.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1355505-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.